---
title: "Entyvio (vedolizumab), all indications: Indication questions"
description: "Indication questions on Entyvio (vedolizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: When was Entyvio first approved by the FDA? What is the generic name of Entyvio? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/entyvio/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Entyvio (vedolizumab), all indications: Indication questions

Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.  
Prescribing information: [Entyvio](https://content.takeda.com/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1)  
Indication pages: [Ulcerative colitis](https://www.evicenter.com/medical-information/entyvio--ulcerative-colitis)

## Indication

<a id="entyvio-approval-date"></a>

### When was Entyvio first approved by the FDA?

> “ENTYVIO IV was FDA approved in May 2014.”

Source: [ENTYVIO: ENTYVIO® (vedolizumab) - Official HCP Website, captured 2026-11-13](https://www.entyviohcp.com/#:~:text=ENTYVIO%20IV%20was%20FDA%20approved%20in%20May%202014.)

> “Initial U.S. Approval: 2014”

Source: [ENTYVIO: Prescribing information, page 1, captured 2026-11-13](https://content.takeda.com/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1#page=1)

## Drug names

<a id="entyvio-generic-name"></a>

### What is the generic name of Entyvio?

> “ENTYVIO (vedolizumab) for injection, for intravenous use
> ENTYVIO (vedolizumab) injection, for subcutaneous use
> ENTYVIO PEN (vedolizumab) injection, for subcutaneous use”

Source: [ENTYVIO: Prescribing information, page 1, captured 2026-11-13](https://content.takeda.com/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1#page=1)

> “Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody 
> produced in Chinese hamster ovary cells that binds to the human α4β7 integrin.”

Source: [ENTYVIO: Prescribing information, page 4, captured 2026-11-13](https://content.takeda.com/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1#page=4)

## Related pages
- [Medical information: Entyvio (vedolizumab): All indications](https://www.evicenter.com/medical-information/entyvio)
- [Pharmacology](https://www.evicenter.com/medical-information/entyvio/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/entyvio/safety)
- [Specific populations](https://www.evicenter.com/medical-information/entyvio/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/entyvio/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/entyvio/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/entyvio/access-and-coverage)
